We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.84B
AUM Growth
-$331M
Cap. Flow
-$98.6M
Cap. Flow %
-3.47%
Top 10 Hldgs %
46.08%
Holding
156
New
25
Increased
37
Reduced
37
Closed
20

Top Buys

Rank Stock Value
1
PAYA
Paya Holdings Inc. Class A Common Stock
PAYA
+$18.8M
2
QURE icon
uniQure
QURE
+$17.3M
3
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
+$16.6M
4
SMLR
Semler Scientific
SMLR
+$15M
5
RMR icon
The RMR Group
RMR
+$11.7M

Top Sells

Rank Stock Value
1
QADA
QAD Inc.
QADA
+$81M
2
VG
Vonage Holdings Corporation
VG
+$47.8M
3
CDXS icon
Codexis
CDXS
+$17.6M
4
CASH icon
Pathward Financial
CASH
+$15.3M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 27.36%
2 Consumer Discretionary 9.53%
3 Financials 4.77%
4 Industrials 4.39%
5 Technology 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAUT icon
76
Nautilus Biotechnolgy
NAUT
$110M
$5.33M 0.19%
1,029,872
-14,395
-1% -$77K
HYPR icon
77
Hyperfine
HYPR
$101M
$5.21M 0.18%
+718,637
New +$5.69M
IMTXW
78
DELISTED
Immatics N.V. Warrants
IMTXW
$4.7M 0.17%
1,071,466
+844,995
+373% +$3.18M
SNDX icon
79
CALL
Syndax Pharmaceuticals
SNDX
$1.82B
$4.38M 0.15%
+200,000
New +$3.7M
SLNO
80
DELISTED
Soleno Therapeutics
SLNO
$4M 0.14%
651,009
– –
ARYD
81
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$3.96M 0.14%
399,248
– –
ZGNX
82
CALL
DELISTED
Zogenix, Inc.
ZGNX
$3.84M 0.14%
+236,400
New +$3.46M
BGFV
83
PUT
DELISTED
Big 5 Sporting Goods
BGFV
$3.8M 0.13%
+200,000
New +$4.99M
ZVO
84
DELISTED
Zovio Inc. Common Stock
ZVO
$3.79M 0.13%
2,980,767
-20,423
-0.7% -$35.8K
ELTX icon
85
Elicio Therapeutics
ELTX
$81.4M
$3.67M 0.13%
126,703
+114,851
+969% +$5.81M
PTON icon
86
Peloton Interactive
PTON
$2.42B
$3.66M 0.13%
+102,342
New +$6.25M
HARP
87
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3.59M 0.13%
47,547
+5,699
+14% +$389K
PWP icon
88
Perella Weinberg Partners
PWP
$1.26B
$3.58M 0.13%
278,140
-202,644
-42% -$2.67M
FAZE
89
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$3.54M 0.12%
+349,649
New +$3.57M
KURA icon
90
CALL
Kura Oncology
KURA
$874M
$3.5M 0.12%
+250,000
New +$4.05M
NPCE icon
91
Neuropace
NPCE
$507M
$3.08M 0.11%
305,906
+164,265
+116% +$2.13M
PAYO icon
92
Payoneer
PAYO
$2.4B
$2.93M 0.1%
398,684
-256,485
-39% -$1.97M
WVE icon
93
Wave Life Sciences
WVE
$1.2B
$2.85M 0.1%
907,094
-87,037
-9% -$361K
BACK
94
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$2.73M 0.1%
79,736
-741
-0.9% -$28.9K
GYRE icon
95
Gyre Therapeutics
GYRE
$713M
$2.52M 0.09%
368,221
+43,926
+14% +$751K
IMV
96
DELISTED
IMV Inc. Common Shares
IMV
$2.51M 0.09%
205,521
-21,282
-9% -$322K
IDW
97
DELISTED
IDW Media Holdings
IDW
$2.46M 0.09%
1,229,243
-13,000
-1% -$35.5K
MILE
98
DELISTED
Metromile, Inc. Common Stock
MILE
$2.45M 0.09%
1,119,612
-780,565
-41% -$2.22M
LUCD icon
99
Lucid Diagnostics
LUCD
$183M
$2.34M 0.08%
+435,055
New +$3.53M
KROS icon
100
CALL
Keros Therapeutics
KROS
$212M
$2.32M 0.08%
+39,700
New +$1.98M
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Nantahala Capital Management held 156 positions worth $2.84B, down 10% from $3.17B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nantahala Capital Management withdrew a net $98.6M in Q4 2021, closing 20 positions and reducing 37 holdings. Its most notable exit was QAD Inc., an estimated $81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Nantahala Capital Management opened a new position in SANTANDER CONSUMER USA HOLDINGS INC worth $16.6M.

  • Nantahala Capital Management's largest Q4 2021 buy was SANTANDER CONSUMER USA HOLDINGS INC: 395,176 shares worth $16.6M.
  • Nantahala Capital Management added most to Paya Holdings Inc. Class A Common Stock in Q4 2021, an estimated $18.8M increase.
  • Nantahala Capital Management's biggest Q4 2021 reduction was Codexis, cutting an estimated $17.6M.
  • Nantahala Capital Management fully exited QAD Inc. in Q4 2021, selling an estimated $81M.
  • Nantahala Capital Management's ten largest holdings make up 46% of its $2.84B portfolio in Q4 2021.
  • Nantahala Capital Management opened 25 new positions and closed 20 in Q4 2021.
  • Nantahala Capital Management's portfolio value fell 10% quarter-over-quarter to $2.84B.

Based on Nantahala Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.